Acorda Files Tender Offer Document Relating to Public Tender Offer for Biotie Therapies with Finnish Financial Supervisory Authority

As announced on January 19, 2016, Acorda Therapeutics, Inc.

and Biotie Therapies Corp.

have entered into a Combination Agreement pursuant to which Acorda will make a voluntary public tender offer in Finland and in the United States to acquire all of the issued and outstanding shares, American Depositary Shares, stock options, share units and warrants in Biotie that are not owned by Biotie or any of its subsidiaries (the "Tender Offer"). Acorda has filed the tender offer document with the Finnish Financial Supervisory Authority ("FIN-FSA") for approval. Acorda will commence the offer period under the Tender Offer as soon as practicable after the receipt of both the FIN-FSA approval of the tender offer document and certain regulatory relief from the US Securities and Exchange Commission ("SEC"). Currently, the offer period is expected to commence by mid-March 2016.